Results 51 to 60 of about 3,769 (208)

Clinical Effect of Ambroxol Hydrochloride Injection on 83 Patients with Acute Exacerbation of Chronic Bronchitis [PDF]

, 2018
Objective: To discuss the effect of ambroxol hydrochloride injection on acute exacerbation of chronic bronchitis. Method: 83 cases of patients with acute exacerbation of chronic bronchitis were randomly divided into observation group and control group ...
He, Hengzhao
core   +1 more source

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis

Frontiers in Pharmacology, 2019
Amyotrophic lateral sclerosis (ALS) is a multifactorial and fatal neurodegenerative disease. Growing evidence connects sphingolipid metabolism to the pathophysiology of ALS.
Alexandra Bouscary, Alexandra Bouscary, Cyril Quessada, Cyril Quessada, Althéa Mosbach, Althéa Mosbach, Noëlle Callizot, Michael Spedding, Jean-Philippe Loeffler, Jean-Philippe Loeffler, Alexandre Henriques, Alexandre Henriques, Alexandre Henriques   +12 more
doaj   +1 more source

Precision Medicine in Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders: An Update on Emerging Treatments

Movement Disorders Clinical Practice, Volume 13, Issue 10, Page 2405-2418, October 2026.
Abstract Background Neurodegeneration with Brain Iron Accumulation (NBIA) is a heterogeneous group of heritable, mostly recessive, progressive neurodegenerative diseases characterized by iron deposition in the basal ganglia and brainstem. There are no solid global epidemiological data on prevalence and incidence of NBIA subtypes, but registry data and ...
Susanne A. Schneider, Divyani Garg, Vassilena Iankova, Thomas Klopstock   +3 more
wiley   +1 more source

Penetapan Harga untuk Peningkatan Penjualan Produk Obat Ambroxol pada PT. XYZFARM Bandung [PDF]

This research aims to test pricing to increase sales of Ambroxol medicinal products at PT. XYZFARM Bandung. Sales data for the drug Ambroxol from January to December 2022 were analyzed using a simple regression analysis method.
Simamora, Risa Mei, Sudrartono, Tiris
core   +1 more source

Mucin histochemistry of tracheal goblet cells after oral administration of ambroxol. Acta vet Brno 2001; 70 [PDF]

, 2020
Vajner L., V. Konrádová, J. Uhlík, J. Zocová: Mucin Histochemistry of Tracheal Goblet Cells after Oral Administration of Ambroxol. Acta Vet. Brno 2001, 70: 9-13.
CSc Mvdr Ludûk Vajner, J Uhlík, L Vajner, V Konrádová, J Zocová   +4 more
core  

The Use of an Ambroxol Solution to Assess Acute Dermal Irritation on Rabbit Skin [PDF]

, 2023
Ambroxol can overcome infections due to the presence of biofilms in the body by interfering with the formation of sticky biofilms and reducing biofilm production, so it has the potential to be used in topical preparations for the treatment of infections.
Wahyuddin, Munifah, Vera Olfiana, Mukhriani, Titik Nuryastuti, Rizka Humardewayanti Asdie, Ika Puspita Sari   +5 more
core   +1 more source

Guideline for Medication Management of Distressing Symptoms in Older Patients Receiving End‐of‐Life Palliative Care

Journal of Evidence-Based Medicine, Volume 19, Issue 3, September 2026.
ABSTRACT Older patients receiving end‐of‐life palliative care often present with multiple geriatric syndromes, frailty, and comorbid symptom burden, resulting in a high risk of medication‐related harm. This guideline focuses on pharmacological management of distressing symptoms in older patients receiving end‐of‐life or hospice‐oriented palliative care,
Daiping Li, Yanwu Yang, Yan Zhang, Jirong Yue, Birong Dong, Meiling Ge, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University   +7 more
wiley   +1 more source

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders

Clinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 357-374, August 2026.
Parkinsonian disorders, including Parkinson's disease, Lewy body dementia, multiple system atrophy, and progressive supranuclear palsy, are progressive neurodegenerative conditions with no treatment options to slow disease progression. This systematic review provides an overview of evidence of disease‐modifying therapies that have been evaluated in ...
Pepijn P.N.M. Eijsvogel, Lars M.G. Smits, Philip H.C. Kremer, Geert Jan Groeneveld   +3 more
wiley   +1 more source

Use of Ambroxol as Therapy for Gaucher Disease

JAMA Network Open, 2023
ImportanceAmbroxol was identified as an enhancer of stability and residual activity of several misfolded glucocerebrosidase variants in 2009.ObjectivesTo assess hematologic and visceral outcomes, biomarker changes, and safety of ambroxol therapy for patients with Gaucher disease (GD) without disease-specific treatment.Design, Setting, and ...
Zhan, Xia, Zhang, Huiwen, Maegawa, Gustavo H. B., Wang, Yu, Gao, Xiaolan, Wang, Dengbin, Li, Jinning   +6 more
openaire   +2 more sources

Efficacy and Safety of Lianhua Qingke Tablets in Children With Mycoplasma pneumoniae Pneumonia: A Randomized, Double‐Blind, Multicenter, Placebo‐Controlled Clinical Trial

The Clinical Respiratory Journal, Volume 20, Issue 7, July 2026.
In this randomized, double‐blind, placebo‐controlled trial involving 160 children with mild Mycoplasma pneumoniae pneumonia, adding Lianhua Qingke tablets to conventional therapy significantly improved symptom resolution by Day 7 (85.9% vs. 65.6%) and shortened median recovery time (4.5 vs.
He Wang, Haiwei Dou, Guangying Chen, Yanmin Wei, Hua Li, Shuqiong Xu, Rongzhen Kang, Shanhong Liu, Long Zhang, Nan Li, Hongli Sun, Chi Wang, Jie Zhao, Jirong Yi, Wentao Song, Hongrong Li, Rong Ma, Kunling Shen, Deli Xin, Wenjie Qi   +19 more
wiley   +1 more source